Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Head and Neck Cancer
Interventions
OTHER

functional MRI

Functional MRI on day 22 of the chemoradiotherapy treatment. Parameters of these images will be later on correlated with outcome.

OTHER

Hypoxia gene expression profile.

Tumour biopsies will be obtained as part of the staging procedure (standard). On this biopsies we will conduct a hypoxia gene expression profile (15 genes on PCR that can be analyzed individually or as a group through one binary variable). Hypoxia will be a parameter in our prognostic/predictive model.

OTHER

Functional MRI before start of treatment.

As part of the standard staging procedure all patients will undergo an MRI of the neck. We will however also take DWI and DCE images at this time point. Parameters of these images will be later on correlated with outcome.

Trial Locations (1)

3000

RECRUITING

Departement of Radiation Oncology, Leuven

All Listed Sponsors
collaborator

Flemish League Against Cancer

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER